BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35064645)

  • 1. The incidence and clinical features of familial pancreatic cancer in Korea.
    Kim M; Kim H; Han Y; Sohn H; Lee M; Kang YH; Kim HS; Kwon W; Jang JY
    J Hepatobiliary Pancreat Sci; 2022 Jun; 29(6):659-669. PubMed ID: 35064645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of familial pancreatic cancer on postoperative outcome in pancreatic cancer: relevance to adjuvant chemotherapy.
    Tezuka K; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Uesaka K
    J Gastroenterol; 2021 Jan; 56(1):101-113. PubMed ID: 33094352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and pathologic features of familial pancreatic cancer.
    Humphris JL; Johns AL; Simpson SH; Cowley MJ; Pajic M; Chang DK; Nagrial AM; Chin VT; Chantrill LA; Pinese M; Mead RS; Gill AJ; Samra JS; Kench JG; Musgrove EA; Tucker KM; Spigelman AD; Waddell N; Grimmond SM; Biankin AV;
    Cancer; 2014 Dec; 120(23):3669-75. PubMed ID: 25313458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of "gene-environment" interaction in cases of familial and sporadic pancreatic cancer.
    Yeo TP; Hruban RH; Brody J; Brune K; Fitzgerald S; Yeo CJ
    J Gastrointest Surg; 2009 Aug; 13(8):1487-94. PubMed ID: 19459017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial pancreatic cancer: Concept, management and issues.
    Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T
    World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update of familial pancreatic cancer in Germany.
    Bartsch DK; Sina-Frey M; Ziegler A; Hahn SA; Przypadlo E; Kress R; Gerdes B; Rieder H
    Pancreatology; 2001; 1(5):510-6. PubMed ID: 12120230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals.
    Zogopoulos G; Haimi I; Sanoba SA; Everett JN; Wang Y; Katona BW; Farrell JJ; Grossberg AJ; Paiella S; Klute KA; Bi Y; Wallace MB; Kwon RS; Stoffel EM; Wadlow RC; Sussman DA; Merchant NB; Permuth JB; Golan T; Raitses-Gurevich M; Lowy AM; Liau J; Jeter JM; Lindberg JM; Chung DC; Earl J; Brentnall TA; Schrader KA; Kaul V; Huang C; Chandarana H; Smerdon C; Graff JJ; Kastrinos F; Kupfer SS; Lucas AL; Sears RC; Brand RE; Parmigiani G; Simeone DM;
    J Natl Compr Canc Netw; 2024 Apr; 22(3):158-166. PubMed ID: 38626807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial Pancreatic Cancer and Surveillance of High-Risk Individuals.
    Matsubayashi H; Takaori K; Morizane C; Kiyozumi Y
    Gut Liver; 2019 Sep; 13(5):498-505. PubMed ID: 30917631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is screening for pancreatic cancer in high-risk groups cost-effective? - Experience from a Danish national screening program.
    Joergensen MT; Gerdes AM; Sorensen J; Schaffalitzky de Muckadell O; Mortensen MB
    Pancreatology; 2016; 16(4):584-92. PubMed ID: 27090585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomas.
    Harinck F; Kluijt I; van der Stoep N; Oldenburg RA; Wagner A; Aalfs CM; Sijmons RH; Poley JW; Kuipers EJ; Fockens P; van Os TA; Bruno MJ
    J Med Genet; 2012 Jun; 49(6):362-5. PubMed ID: 22636603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome.
    Lener MR; Kashyap A; Kluźniak W; Cybulski C; Soluch A; Pietrzak S; Huzarski T; Gronwald J; Lubiński J
    Cancer Res Treat; 2017 Apr; 49(2):430-436. PubMed ID: 27488870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.
    Tersmette AC; Petersen GM; Offerhaus GJ; Falatko FC; Brune KA; Goggins M; Rozenblum E; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Clin Cancer Res; 2001 Mar; 7(3):738-44. PubMed ID: 11297271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families.
    Slater EP; Langer P; Fendrich V; Habbe N; Chaloupka B; Matthäi E; Sina M; Hahn SA; Bartsch DK
    Fam Cancer; 2010 Sep; 9(3):335-43. PubMed ID: 20195775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of age of onset in pancreatic cancer kindreds.
    Brune KA; Lau B; Palmisano E; Canto M; Goggins MG; Hruban RH; Klein AP
    J Natl Cancer Inst; 2010 Jan; 102(2):119-26. PubMed ID: 20068195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds.
    Klein AP; Brune KA; Petersen GM; Goggins M; Tersmette AC; Offerhaus GJ; Griffin C; Cameron JL; Yeo CJ; Kern S; Hruban RH
    Cancer Res; 2004 Apr; 64(7):2634-8. PubMed ID: 15059921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cohort profile and heritability assessment of familial pancreatic cancer: a nation-wide study.
    Tan M; Brusgaard K; Gerdes AM; Mortensen MB; Detlefsen S; Schaffalitzky de Muckadell OB; Joergensen MT
    Scand J Gastroenterol; 2021 Aug; 56(8):965-971. PubMed ID: 34165379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.
    Langer P; Kann PH; Fendrich V; Habbe N; Schneider M; Sina M; Slater EP; Heverhagen JT; Gress TM; Rothmund M; Bartsch DK
    Gut; 2009 Oct; 58(10):1410-8. PubMed ID: 19470496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.
    Vasen H; Ibrahim I; Ponce CG; Slater EP; Matthäi E; Carrato A; Earl J; Robbers K; van Mil AM; Potjer T; Bonsing BA; de Vos Tot Nederveen Cappel WH; Bergman W; Wasser M; Morreau H; Klöppel G; Schicker C; Steinkamp M; Figiel J; Esposito I; Mocci E; Vazquez-Sequeiros E; Sanjuanbenito A; Muñoz-Beltran M; Montans J; Langer P; Fendrich V; Bartsch DK
    J Clin Oncol; 2016 Jun; 34(17):2010-9. PubMed ID: 27114589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of Individuals with a Family History of Pancreatic Cancer and Inherited Cancer Syndromes: A Strategy for Detecting Early Pancreatic Cancers.
    Matsubayashi H; Kiyozumi Y; Ishiwatari H; Uesaka K; Kikuyama M; Ono H
    Diagnostics (Basel); 2019 Oct; 9(4):. PubMed ID: 31683730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.